NCT01112722已完成3 期
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 363
- 试验地点
- 28
- 主要终点
- WOMAC
研究概览
简要总结
The study will identify the efficacy of Apitox, purified honeybee toxin, in 330 patients with diagnosed osteoarthritis of the knee. The subjects will be evaluated for relief of pain using Western Ontario and McMaster Osteoarthritis Index (WOMAC) and Physician and Patient Global Assessments and primary efficacy measure of relief of pain and inflammation over a 12 week treatment period after randomization into the trial. Secondary efficacy is improvement of mobility Treatment effect will be compared in a 2-1 Apitox vs active control
详细描述
feasibility and Site selection has been completed in the US and India
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 30 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •osteoarthritis of one or both knees
- •on stable NSAID or none due to intolerance
- •women either post menopausal or on stable birth control
- •no clinically significant disease or or abnormal laboratory values
- •signed informed consent, communicate effectively, understand and comply with all study requirements
排除标准
- •serious or unstable medical or psychological condition
- •known sensitivity to honeybee venom, histamine or lidocaine
- •history of asthma
- •any clinically significant ECG abnormalities
- •any clinically significant laboratory values OOR
- •history of drug or alcohol abuse
- •history of joint injury and forms of inflammatory arthritis
结局指标
主要结局
WOMAC
时间窗: from 4 wks dose escalation thru 12 weeks treatment dose to 4 wks follow up
WOMAC
次要结局
- PGA(from 4 wks throught the 12 wk treatment)
- PhGA(from 4 wks global assessment through 12 wks)
研究者
研究点 (28)
Loading locations...
相似试验
已完成
3 期
Pioglitazone Add-on Study in Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT00086502Merck Sharp & Dohme LLC353
已完成
3 期
Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)Diabetes Mellitus, Type IINCT00086515Merck Sharp & Dohme LLC701
已完成
3 期
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisPsoriasisNCT02905331Janssen Research & Development, LLC78
Unknown
3 期
Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute GoutAcute GoutNCT02674776Quan Jiang480
已完成
3 期
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)Plaque PsoriasisNCT02742441Therapeutics, Inc.409